TaiwanJ Pharmaceuticals Co (ROCO:6549) Change In Receivables : NT$4.51 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is TaiwanJ Pharmaceuticals Co Change In Receivables?

TaiwanJ Pharmaceuticals Co's change in receivables for the quarter that ended in Dec. 2023 was NT$-0.01 Mil. It means TaiwanJ Pharmaceuticals Co's Accounts Receivable increased by NT$0.01 Mil from Jun. 2023 to Dec. 2023 .

TaiwanJ Pharmaceuticals Co's change in receivables for the fiscal year that ended in Dec. 2023 was NT$4.51 Mil. It means TaiwanJ Pharmaceuticals Co's Accounts Receivable declined by NT$4.51 Mil from Dec. 2022 to Dec. 2023 .

TaiwanJ Pharmaceuticals Co's Accounts Receivable for the quarter that ended in Dec. 2023 was NT$0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. TaiwanJ Pharmaceuticals Co's liquidation value for the six months ended in Dec. 2023 was NT$52.21 Mil.

TaiwanJ Pharmaceuticals Co Change In Receivables Historical Data

The historical data trend for TaiwanJ Pharmaceuticals Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiwanJ Pharmaceuticals Co Change In Receivables Chart

TaiwanJ Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-15.54

4.51

TaiwanJ Pharmaceuticals Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	4.52	-0.01

TaiwanJ Pharmaceuticals Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$4.51 Mil.

TaiwanJ Pharmaceuticals Co (ROCO:6549) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

TaiwanJ Pharmaceuticals Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, TaiwanJ Pharmaceuticals Co's accounts receivable are only considered to be worth 75% of book value:

TaiwanJ Pharmaceuticals Co's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	58.829	-	6.618	+	0.75 * 0	+	0.5 * 0
=	52.21

TaiwanJ Pharmaceuticals Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of TaiwanJ Pharmaceuticals Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

TaiwanJ Pharmaceuticals Co (ROCO:6549) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiwanJ Pharmaceuticals Co Ltd (ROCO:6549) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rm. D207, Number 2, Sec.2, ShengYi Road, Hsinchu Biomedical Science Park, Hsinchu County, Zhubei, TWN, 30261

Website

http://www.taiwanj.com

TaiwanJ Pharmaceuticals Co Ltd is a Taiwan based specialty pharmaceutical company focused on small molecules for unmet medical needs like chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It is also involved in developing novel chemical entities (NCEs) for chronic liver diseases and allergy/asthma.

TaiwanJ Pharmaceuticals Co (ROCO:6549) Headlines

No Headlines